XML 139 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
Derivative Instruments - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2022
Jun. 30, 2018
Feb. 29, 2012
Derivatives, Fair Value [Line Items]            
Range of durations of foreign currency forward contracts 12 months          
Net gains (losses) of other income (expense) related to foreign currency forward contracts $ 3.8 $ (34.7) $ (43.3)      
Samsung Bioepis            
Derivatives, Fair Value [Line Items]            
Gain on derivative used in net investment hedge 57.0          
Net investment hedge            
Derivatives, Fair Value [Line Items]            
Derivative qualifying as hedge gain (loss), excluded component, after tax     (3.6)      
Samsung Bioepis            
Derivatives, Fair Value [Line Items]            
Ownership percentage before additional purchase transaction         5.00%  
Ownership percentage       49.90%   15.00%
Not designated as hedging instrument            
Derivatives, Fair Value [Line Items]            
Derivative, notional amount 1,301.5 1,238.8        
Foreign Exchange Forward            
Derivatives, Fair Value [Line Items]            
Unrealized gain (loss) on derivative instruments $ (34.8) $ 8.6 53.8      
Foreign Exchange Forward | Net investment hedge            
Derivatives, Fair Value [Line Items]            
Unrealized gain (loss) on derivative instruments     $ 10.6      
Minimum            
Derivatives, Fair Value [Line Items]            
Range of durations of foreign currency forward contracts 1 month 1 month        
Maximum            
Derivatives, Fair Value [Line Items]            
Range of durations of foreign currency forward contracts 12 months 12 months